Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PHILLIP J SEEREITER

Allopathic & Osteopathic Physicians Urology

NPI
1447429576
CMS profile
546618
Location
ORCHARD PARK, NY

General Payments · PY2018–2024

$4,199.40

  • Reported across 264 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$302.40

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $302.40 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
180 Medical, Inc. $79.70 4
ABBVIE INC. $60.81 3
Astellas Pharma US Inc $52.94 3
UROGEN PHARMA, INC. $51.81 2
Olympus America Inc. $22.42 1
Merck Sharp & Dohme Corporation $18.52 1
PFIZER INC. $16.20 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $817.07 45
PY2019 $633.17 47
PY2020 $409.52 27
PY2021 $741.48 47
PY2022 $754.16 51
PY2023 $541.60 32
PY2024 $302.40 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
180 Medical, Inc. $17.01 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151365288 CMS
180 Medical, Inc. $20.63 04/12/2024 Food and Beverage Undisputed 01/23/2026 1151365290 CMS
180 Medical, Inc. $21.06 05/31/2024 Food and Beverage Undisputed 01/23/2026 1151365292 CMS
180 Medical, Inc. $21.00 08/30/2024 Food and Beverage Undisputed 01/23/2026 1151365294 CMS
ABBVIE INC. $18.82 01/10/2024 Food and Beverage Undisputed 01/23/2026 1106051420 CMS
ABBVIE INC. $22.80 06/05/2024 Food and Beverage Undisputed 01/23/2026 1106051422 CMS
ABBVIE INC. $19.19 09/25/2024 Food and Beverage Undisputed 01/23/2026 1106051424 CMS
Astellas Pharma US Inc $21.03 02/09/2024 Food and Beverage Undisputed 01/23/2026 1139317976 CMS
Astellas Pharma US Inc $14.63 03/22/2024 Food and Beverage Undisputed 01/23/2026 1139302212 CMS
Astellas Pharma US Inc $17.28 05/10/2024 Food and Beverage Undisputed 01/23/2026 1139354777 CMS
Merck Sharp & Dohme LLC $18.52 02/07/2024 Food and Beverage Undisputed 01/23/2026 1141816147 CMS
Olympus America Inc. $22.42 07/30/2024 Food and Beverage Undisputed 01/23/2026 1108475684 CMS
PFIZER INC. $16.20 03/20/2024 Food and Beverage Undisputed 01/23/2026 1131300300 CMS
UROGEN PHARMA, INC. $27.67 04/17/2024 Food and Beverage Undisputed 01/23/2026 1137917785 CMS
UROGEN PHARMA, INC. $24.14 09/06/2024 Food and Beverage Undisputed 01/23/2026 1137919175 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.